N

Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538

Watchlist Manager
Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538
Watchlist
Price: 21.18 CNY 0.05%
Market Cap: 4.7B CNY

Wall Street
Price Targets

Price Targets Summary
Ningbo Menovo Pharmaceutical Co Ltd

There are no price targets for Ningbo Menovo Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ningbo Menovo Pharmaceutical Co Ltd Competitors:
Price Targets
688185
CanSino Biologics Inc
1% Upside
INDOCO
Indoco Remedies Ltd
29% Upside
2005
SSY Group Ltd
30% Upside
STAR
Strides Pharma Science Ltd
38% Upside
LQDA
Liquidia Corp
18% Upside
XERS
Xeris Biopharma Holdings Inc
47% Upside
LINCOLN
Lincoln Pharmaceuticals Ltd
115% Upside
170900
Dong-A ST Co Ltd
28% Upside

Revenue
Forecast

Revenue Estimate
Ningbo Menovo Pharmaceutical Co Ltd

For the last 9 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's revenue is 10%. The projected CAGR for the next 3 years is 21%.

10%
Past Growth
21%
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ningbo Menovo Pharmaceutical Co Ltd

For the last 9 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's operating income is 5%.

5%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss

Net Income
Forecast

Net Income Estimate
Ningbo Menovo Pharmaceutical Co Ltd

For the last 9 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's net income is -2%. The projected CAGR for the next 3 years is 48%.

-2%
Past Growth
48%
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ningbo Menovo Pharmaceutical Co Ltd's stock price target?
Not Available

Ningbo Menovo Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Ningbo Menovo Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
21%

For the last 9 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's revenue is 10%. The projected CAGR for the next 3 years is 21%.

What is Ningbo Menovo Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
48%

For the last 9 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's net income is -2%. The projected CAGR for the next 3 years is 48%.

Back to Top